Common osteoporosis drugs are associated with a decrease in risk of breast cancer
March 1, 2010 by admin · Leave a Comment
Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
SEATTLE Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S. researchers published today in the British Journal of Cancer.
Freezing breast tumors helps stop cancers spread in mice, U-M study finds
March 1, 2010 by admin · Leave a Comment
Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System Read more
New subtype of breast cancer responds to targeted drug
February 28, 2010 by admin · Leave a Comment
Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
A newly identified cancer biomarker could define a new subtype of breast cancer as well as offer a potential way to treat it, say researchers at Washington University School of Medicine in St. Louis. Their findings will be published in the March 1 online early edition issue of the Proceedings of the National Academy of Sciences.
Bitter melon extract attacks breast cancer cells
February 22, 2010 by admin · Leave a Comment
Contact: Nancy Solomon
solomonn@slu.edu
314-977-8017
Saint Louis University Read more
Synthetic lethality: A new way to kill cancer cells
February 21, 2010 by admin · Leave a Comment
Contact: Steve Pogonowski
press@f1000.com
Faculty of 1000: Biology and Medicine
Ovarian and breast cancer treatments being developed that mix a protein inhibitor and traditional anticancer drugs are showing signs of success, according to a new review for Faculty of 1000 Biology Reports.
Researchers develop standard of care for breast cancer survivors with lymphedema
February 16, 2010 by admin · Leave a Comment
Contact: Emily Martin
MartinEm@missouri.edu
573-882-3346
University of Missouri-Columbia
COLUMBIA, Mo. Lymphedema, a chronic swelling condition that can appear after breast cancer surgery, is a risk for 1.3 million breast cancer survivors. Although lymphedema can cause lifelong swelling in the arms, back, neck and chest, there is no national standard of diagnosis or care. Now, University of Missouri researchers are leading the American Lymphedema Framework Project (ALFP), a national, multi-disciplinary collaboration to develop comprehensive guidelines for the assessment, treatment, and management of lymphedema.
Master gene SRC-3 enables breast cancer growth, invasion
February 11, 2010 by admin · Leave a Comment
Contact: Dipali Pathak
pathak@bcm.edu
713-798-4710
Baylor College of Medicine
HOUSTON - (Feb. 12, 2009) The master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a protein, it also sends a signal to the cell membrane to promote cell motility or movement a key element of cancer spread or metastasis, said Baylor College of Medicine (www.bcm.edu) researchers and collaborators in a report that appears in the current issue of the journal Molecular Cell.
Short-term radiation therapy successful on breast cancer
February 9, 2010 by admin · Leave a Comment
Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University Read more
New approach to treating breast and prostate cancers
February 4, 2010 by admin · Leave a Comment
Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System Read more
Genes found linked to breast cancer drug resistance could guide future treatment choices
January 23, 2010 by admin · Leave a Comment
Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
BOSTON–Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.
